Transient expansion of vestibular schwannoma following stereotactic radiosurgery

被引:121
|
作者
Nagano, Osamu [1 ]
Higuchi, Yoshinori
Serizawa, Toru [3 ]
Ono, Junichi [2 ]
Matsuda, Shinji [4 ]
Yamakami, Iwao
Saeki, Naokatsu
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuou Ku, Chiba 2600856, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan
[3] Chiba Cardiovasc Ctr, Gamma Knife House, Ichihara, Chiba, Japan
[4] Chiba Cardiovasc Ctr, Dept Neurol, Ichihara, Chiba, Japan
关键词
facial nerve function; Gamma Knife surgery; stereotactic radiosurgery; transient tumor expansion; trigeminal nerve dysesthesia; vestibular schwannoma;
D O I
10.3171/JNS/2008/109/11/0811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after stereotactic radiosurgery. Methods. One hundred Consecutive patients with unilateral VS treated with Gamma Knife Surgery (GKS) at Chiba Cardiovascular Center between 1998 and 2006 were analyzed in this study. For each lesion the Gd-enhanced volume was measured serially every 3 months in the 1st year, then every 6 months thereafter, using volumetric software. The frequency and degree of transient tumor expansion were documented and possible prognostic factors were analyzed. Concurrently, neurological deterioration involving trigeminal, facial, and cochlear nerve functions were also assessed. Results. The mean observation period was 65 months (range 25-100 months). There were 32 men and 68 women whose mean age was 59.1 years (range 29-80 years). Tumor volumes at GKS averaged 2.7 cm(3) (range 0.1-13.2 C 113), and the lesions were irradiated at the mean 52.2% isodose line for the tumor margin (range 50-67%), with a mean dose of 12.2 Gy (range 10.5-13 Gy) at the periphery. The tumor Volume was increased by 23% at 3 months and 27% at 6 months. Tumors shrank to their initial size over a mean period of 12 months. The maximum volume increase was < 10% (no significant increase) in 26 patients, 10-30% in 23, 30-50% in 22, 50-100% in 16, and > 100% in 13. The peak tumor expansion averaged 47% (range 0-613%). A high-dose (>= 3.5 Gy/min) treatment appears to be the greatest risk factor for transient tumor expansion, although the difference did not reach statistical significance. Transient facial palsy and facial dysesthesia correlated strongly with tumor expansion, but only half of the hearing loss was coincident with this phenomenon. Conclusions. Transient expansion of VSs after GKS was found to be much more frequent than previously reported, strongly Suggesting a correlation with deterioration of facial and trigeminal nerve functions.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 50 条
  • [21] Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?
    Linskey, Mark E.
    JOURNAL OF NEUROSURGERY, 2008, 109 : 129 - 136
  • [22] Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery
    Berger, Assaf
    Alzate, Juan Diego
    Bernstein, Kenneth
    Mullen, Reed
    McMenomey, Sean
    Jethanemest, Daniel
    Friedmann, David R.
    Smouha, Eric
    Sulman, Erik P.
    Silverman, Joshua S.
    Roland, J. Thomas
    Golfinos, John G.
    Kondziolka, Douglas
    NEUROSURGERY, 2022, 91 (04) : 648 - 657
  • [23] Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: A systematic review
    Yang, Isaac
    Aranda, Derrick
    Han, Seunggu J.
    Chennupati, Sravana
    Sughrue, Michael E.
    Cheung, Steven W.
    Pitts, Lawrence H.
    Parsa, Andrew T.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (06) : 742 - 747
  • [24] Associations of Microvascular Risk Factors with Sporadic Vestibular Schwannoma Outcomes Following Stereotactic Radiosurgery
    Dornhoffer, James R.
    Babajanian, Eric E.
    Khandalavala, Karl R.
    Marinelli, John P.
    Daher, Ghazal S.
    Lohse, Christine M.
    Link, Michael J.
    Carlson, Matthew L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025, 172 (03) : 967 - 973
  • [25] How to distinguish tumor growth from transient expansion of vestibular schwannomas following Gamma Knife radiosurgery
    Mindermann, Thomas
    Schlegel, Ines
    ACTA NEUROCHIRURGICA, 2014, 156 (06) : 1121 - 1123
  • [26] Microsurgical removal of a vestibular schwannoma after stereotactic radiosurgery: Surgical and pathologic findings
    Schulder, M
    Sreepada, GS
    Kwartler, JA
    Cho, ES
    AMERICAN JOURNAL OF OTOLOGY, 1999, 20 (03): : 364 - 367
  • [27] Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related Schwannomatosis
    Shrivastava, Manu
    Emmanouil, Beatrice
    Mathew, Rajeev
    Halliday, Dorothy
    Parry, Allyson
    Halliday, Jane
    Mackeith, Samuel
    LARYNGOSCOPE, 2024, 134 (05): : 2364 - 2371
  • [28] Stereotactic Radiosurgery in the Management of Vestibular Schwannoma and Glomus Jugulare Indications, Techniques, and Results
    Jacob, Jeffrey T.
    Pollock, Bruce E.
    Carlson, Matthew L.
    Driscoll, Colin L. W.
    Link, Michael J.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2015, 48 (03) : 515 - +
  • [29] Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma
    Kunal S. Patel
    Edwin Ng
    Taranjit Kaur
    Tyler Miao
    Tania Kaprealian
    Percy Lee
    Nader Pouratian
    Michael T. Selch
    Antonio A. F. De Salles
    Quinton Gopen
    Stephen Tenn
    Isaac Yang
    Journal of Neuro-Oncology, 2019, 145 : 329 - 337
  • [30] Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma
    Patel, Kunal S.
    Ng, Edwin
    Kaur, Taranjit
    Miao, Tyler
    Kaprealian, Tania
    Lee, Percy
    Pouratian, Nader
    Selch, Michael T.
    De Salles, Antonio A. F.
    Gopen, Quinton
    Tenn, Stephen
    Yang, Isaac
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (02) : 329 - 337